China’s Shandong Weigao eyes up to RMB 400 million debt securities

By Taylor Fox

New York, Oct. 30 – Shandong Weigao Group Medical Polymer Co. Ltd. is proposing to issue no more than RMB 400 million of debt securities to improve capital efficiency and optimize its asset structure, according to a company announcement.

The securities will have maturities of no more than 20 years.

The proceeds will be used to meet the company’s production and operation needs, for additional working capital and to invest in projects that are in the interests and benefits of the company and its shareholders.

The issuance is subject to shareholders’ approval. Once granted, the approval would be valid for two years.

Based in Shandong, China, Shandong Weigao is engaged in the research and development, production and sale of single-use medical devices.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.